Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
July 7, 2001
Retraction: reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo
L Kanz, W Brugger
Current Opinion in Hematology
|
May 1, 1996
Ex vivo expansion of hematopoietic precursor cells
W Brugger, L Kanz
Nouvelle Revue Francaise D'Hematologie
|
June 1, 1993
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells
W Brugger, R Mertelsmann, L Kanz
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification
L Kanz, W Brugger, R Mertelsmann
Current Protocols
|
December 26, 2023
Influence of Admixture on Phenotypes
Steven W Brugger, Mary F Davis
Seminars in Oncology
|
December 1, 1994
The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation
L Kanz, W Brugger, R Mertelsmann
Journal of Leukocyte Biology
|
May 1, 1991
Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro
W Brugger, M Kreutz, R Andreesen
Stem Cells (Dayton, Ohio)
|
September 30, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cells
L Kanz, W Brugger, S Scheding
Critical Reviews in Oncology/Hematology
|
July 15, 2009
Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support
W Brugger, P Bacon, S Lawrinson, et al.
Vox Sanguinis
|
January 1, 1994
The clinical role of hematopoietic growth factors in peripheral blood progenitor cell transplantation
S Fetscher, W Brugger, R Mertelsmann, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
July 7, 2001
Retraction: reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo
L Kanz, W Brugger
Current Opinion in Hematology
|
May 1, 1996
Ex vivo expansion of hematopoietic precursor cells
W Brugger, L Kanz
Nouvelle Revue Francaise D'Hematologie
|
June 1, 1993
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells
W Brugger, R Mertelsmann, L Kanz
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification
L Kanz, W Brugger, R Mertelsmann
Current Protocols
|
December 26, 2023
Influence of Admixture on Phenotypes
Steven W Brugger, Mary F Davis
Seminars in Oncology
|
December 1, 1994
The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation
L Kanz, W Brugger, R Mertelsmann
Journal of Leukocyte Biology
|
May 1, 1991
Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro
W Brugger, M Kreutz, R Andreesen
Stem Cells (Dayton, Ohio)
|
September 30, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cells
L Kanz, W Brugger, S Scheding
Critical Reviews in Oncology/Hematology
|
July 15, 2009
Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support
W Brugger, P Bacon, S Lawrinson, et al.
Vox Sanguinis
|
January 1, 1994
The clinical role of hematopoietic growth factors in peripheral blood progenitor cell transplantation
S Fetscher, W Brugger, R Mertelsmann, et al.
Page
of 12